Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 2 Similar Profiles
Pancreatic Neoplasms Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Survival Medicine & Life Sciences
Tumor Microenvironment Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2018

HALO 202: Randomized phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma

Hingorani, S. R., Zheng, L., Bullock, A. J., Seery, T. E., Harris, W. P., Sigal, D. S., Braiteh, F., Ritch, P. S., Zalupski, M. M., Bahary, N., Oberstein, P. E., Wang-Gillam, A., Wu, W., Chondros, D., Jiang, P., Khelifa, S., Pu, J., Aldrich, C. & Hendifar, A. E. Feb 1 2018 In : Journal of Clinical Oncology. 36, 4, p. 359-366 8 p.

Research output: Contribution to journalArticle

gemcitabine
Hyaluronic Acid
Adenocarcinoma
Paclitaxel
Enoxaparin
Pancreatic Neoplasms
Radiotherapy
Radiation
Drug Therapy
Adenocarcinoma

Precision immuno-oncology: Prospects of individualized immunotherapy for pancreatic cancer

Zhang, J., Wolfgang, C. L. & Zheng, L. Feb 1 2018 In : Cancers. 10, 2, 39

Research output: Contribution to journalReview article

Pancreatic Neoplasms
Immunotherapy
Tumor Microenvironment
Neoplasms
Biomarkers

Stereotactic body radiation therapy for palliative management of pancreatic adenocarcinoma in elderly and medically inoperable patients

Ryan, J. F., Rosati, L. M., Groot, V. P., Le, D. T., Zheng, L., Laheru, D. A., Shin, E. J., Jackson, J., Moore, J., Narang, A. K. & Herman, J. M. Jan 1 2018 In : Oncotarget. 9, 23, p. 16427-16436 10 p.

Research output: Contribution to journalArticle

Adenocarcinoma
Radiotherapy
Disease-Free Survival
Induction Chemotherapy
Survival